Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Henk-Jan Boiten"'
Autor:
Paul J. Hengeveld, P. Martijn Kolijn, Jeroen A.A. Demmers, Wouter Doff, Julie M.N. Dubois, Melissa Rijken, Jorn L.J.C. Assmann, Lina van der Straten, Henk Jan Boiten, Kirsten J. Gussinklo, Peter J.M. Valk, Laura M. Faber, Peter E. Westerweel, Arnon P. Kater, Mark-David Levin, Anton W. Langerak
Publikováno v:
HemaSphere, Vol 7, Iss 10, p e951 (2023)
It remains challenging in chronic lymphocytic leukemia (CLL) to distinguish between patients with favorable and unfavorable time-to-first treatment (TTFT). Additionally, the downstream protein correlates of well-known molecular features of CLL are no
Externí odkaz:
https://doaj.org/article/9c7c2aec214047bd85fc59184f7b706f
Publikováno v:
International Journal of Infectious Diseases, Vol 106, Iss , Pp 262-264 (2021)
Presented is a patient with dyspnea and painful ulcers finally resulting in multi-organ failure. A detailed history resulted in positive PCR testing for Chlamydia psittaci. We emphasize the importance of a definitive history in establishing the corre
Externí odkaz:
https://doaj.org/article/ea2bcd16bee2425188e7f907f98e24d8
Autor:
Paul Hengeveld, Pieter Martijn Kolijn, Jeroen Demmers, Wouter Doff, Julie Dubois, Melissa Rijken, Jorn Assmann, Lina van der Straten, Henk Jan Boiten, Kirsten Gussinklo, Peter Valk, Laura Faber, Peter Westerweel, Arnon Kater, Mark-David Levin, Anton Langerak
It remains challenging in chronic lymphocytic leukemia (CLL) to distinguish between patients with favorable and unfavorable time to first treatment (TTFT). Additionally, the downstream protein correlates of well-known molecular features of CLL are no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f2e7a21a90fe755a7c48aee899349ac
https://doi.org/10.21203/rs.3.rs-2312822/v1
https://doi.org/10.21203/rs.3.rs-2312822/v1
Autor:
Paul Hengeveld, Pieter M. Kolijn, Jeroen A.A. Demmers, Wouter Doff, Julie M.N. Dubois, Melissa Rijken, Jorn Assmann, Lina Van Der Straten, Henk-Jan Boiten, Kirsten J. Gussinklo, Peter J.M. Valk, Peter E. Westerweel, Arnon P. Kater, Anton W. Langerak, Mark-David Levin
Publikováno v:
Blood. 140:9851-9852
Autor:
Trui van Essen, Samara Guillen, Eduard J. Libourel, Ellen M. van der Zwan‐van Beek, Henk‐Jan Boiten
Publikováno v:
British Journal of Haematology. 201:179-179
Publikováno v:
Annals of Hematology, 101(6), 1359-1360. Springer-Verlag
Publikováno v:
British Journal of Clinical Pharmacology. 87:3619-3621
Anti-tumour necrosis factor-α (TNFα) agents are effective in diseases including Crohn's disease but may cause cytopenias. The mechanisms involved in anti-TNFα agent-induced thrombocytopenia are scarce. We report a 73-year-old male with Crohn's dis
Publikováno v:
International Journal of Infectious Diseases, 106, 262-264. Elsevier
International Journal of Infectious Diseases, Vol 106, Iss, Pp 262-264 (2021)
International Journal of Infectious Diseases, Vol 106, Iss, Pp 262-264 (2021)
Presented is a patient with dyspnea and painful ulcers finally resulting in multi-organ failure. A detailed history resulted in positive PCR testing for Chlamydia psittaci. We emphasize the importance of a definitive history in establishing the corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a4e95a8fe774a3b3c70f1e4f21ff51b
https://pure.eur.nl/en/publications/e32ab884-f72f-4641-a65b-99d0400553fe
https://pure.eur.nl/en/publications/e32ab884-f72f-4641-a65b-99d0400553fe
Anti-tumor necrosis factor alpha (TNFα) agents are effective in diseases including Crohn’s disease (CD) but may cause cytopenias. The mechanisms involved in anti-TNFα agents induced thrombocytopenia are scarce. We report a 73-year-old male with C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07613fb2ce6380810fe0c67a7aa3c641
https://doi.org/10.22541/au.161031083.39787297/v1
https://doi.org/10.22541/au.161031083.39787297/v1
Publikováno v:
JAMA-Journal of the American Medical Association, 322(24), 2437-2438. American Medical Association